- Home
- ASPS vs CGTX Comparison
ASPS vs CGTX Comparison
Compare ASPS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- CGTX
- Stock Information
- Founded
- ASPS 1999
- CGTX 2007
- Country
- ASPS Luxembourg
- CGTX United States
- Employees
- ASPS N/A
- CGTX N/A
- Industry
- ASPS Other Consumer Services
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- CGTX Health Care
- Exchange
- ASPS Nasdaq
- CGTX Nasdaq
- Market Cap
- ASPS 19.8M
- CGTX 16.1M
- IPO Year
- ASPS N/A
- CGTX 2021
- Fundamental
- Price
- ASPS $0.62
- CGTX $0.58
- Analyst Decision
- ASPS
- CGTX Buy
- Analyst Count
- ASPS 0
- CGTX 6
- Target Price
- ASPS N/A
- CGTX $8.00
- AVG Volume (30 Days)
- ASPS 188.9K
- CGTX 18.0M
- Earning Date
- ASPS 10-24-2024
- CGTX 11-13-2024
- Dividend Yield
- ASPS N/A
- CGTX N/A
- EPS Growth
- ASPS N/A
- CGTX N/A
- EPS
- ASPS N/A
- CGTX N/A
- Revenue
- ASPS $153,278,000.00
- CGTX N/A
- Revenue This Year
- ASPS $15.33
- CGTX N/A
- Revenue Next Year
- ASPS $32.37
- CGTX N/A
- P/E Ratio
- ASPS N/A
- CGTX N/A
- Revenue Growth
- ASPS 5.19
- CGTX N/A
- 52 Week Low
- ASPS $0.62
- CGTX $0.34
- 52 Week High
- ASPS $3.71
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- ASPS 30.70
- CGTX 65.53
- Support Level
- ASPS $0.71
- CGTX $0.43
- Resistance Level
- ASPS $0.86
- CGTX $0.52
- Average True Range (ATR)
- ASPS 0.08
- CGTX 0.09
- MACD
- ASPS -0.00
- CGTX 0.02
- Stochastic Oscillator
- ASPS 1.14
- CGTX 22.40
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.